Similar companies
Did GoodRx Beat Earnings?
GoodRx (GDRX) reported Q2 '26 revenue of $200M, down 1.3% year-over-year, with reported EPS of $0.04. That matched the $0.04 analyst estimate.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — GoodRx’s job postings, web traffic, and employee business outlook. See the full GDRX stock analysis or the earnings calendar for upcoming reports.
GDRX Earnings Surprise History (EPS vs. Estimate)
| Quarter | Estimated EPS | Reported EPS | Surprise |
|---|---|---|---|
| Q2 '26 | $0.04 | $0.04 | Met +0.0% |
| Q1 '26 | $0.07 | $0.07 | Met +0.0% |
| Q4 '25 | $0.09 | $0.09 | Missed -2.2% |
| Q3 '25 | $0.09 | $0.08 | Missed -11.1% |
| Q2 '25 | $0.10 | $0.09 | Missed -10.0% |
| Q1 '25 | $0.10 | $0.09 | Missed -6.3% |
GoodRx Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 195M | 199M | 203M | 203M | 196M | 195M | 194M | 200M |
| Gross margin | 94.0% | 93.9% | 93.4% | 83.7% | 93.2% | 91.0% | 78.4% | 89.5% |
| Operating margin | 10.5% | 9.2% | 11.5% | 13.6% | 7.5% | 11.6% | 10.1% | 11.8% |
| Net income | 12M | 6.7M | 11M | 13M | 1.1M | 5.4M | 1.2M | 8.5M |
| Net margin | 6.3% | 3.4% | 5.4% | 6.3% | 0.6% | 2.8% | 0.6% | 4.3% |
| EPS | $0.08 | $0.09 | $0.09 | $0.09 | $0.08 | $0.09 | $0.07 | $0.04 |
GoodRx Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, GoodRx’s quarterly revenue moved from $195M to $200M. Net margin compressed from 6.3% to 4.3%, against a 89.5% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit. GoodRx has beaten Wall Street EPS estimates in 2 of its last 8 reported quarters.
When Is GoodRx’s Next Earnings Date?
GoodRx reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the GDRX earnings calendar.
Frequently Asked Questions: GoodRx Earnings
GoodRx's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
GoodRx reported Q2 '26 EPS of $0.04 on revenue of $200M (-1.3% YoY). GoodRx reported EPS of $0.04.
GoodRx reported Q2 '26 revenue of $200M, down 1.3% from the same quarter a year earlier.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the GDRX AI Score.
